Vitamin K antagonists in heart disease: Current status and perspectives (Section III)
R De Caterina, S Husted, L Wallentin… - Thrombosis and …, 2013 - thieme-connect.com
Oral anticoagulants are a mainstay of cardiovascular therapy, and for over 60 years vitamin
K antagonists (VKAs) were the only available agents for long-term use. VKAs interfere with …
K antagonists (VKAs) were the only available agents for long-term use. VKAs interfere with …
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease …
Coordinating Committee, R De Caterina… - Journal of the American …, 2012 - jacc.org
Until recently, vitamin K antagonists were the only available oral anticoagulants, but with
numerous limitations that prompted the introduction of new oral anticoagulants targeting the …
numerous limitations that prompted the introduction of new oral anticoagulants targeting the …
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial …
D Brieger, J Amerena, JR Attia… - Medical Journal of …, 2018 - Wiley Online Library
Introduction: Atrial fibrillation (AF) is increasing in prevalence and is associated with
significant morbidity and mortality. The optimal diagnostic and treatment strategies for AF are …
significant morbidity and mortality. The optimal diagnostic and treatment strategies for AF are …
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk …
Authors/Task Force Members… - European heart …, 2009 - academic.oup.com
Thus, the task of writing Guidelines or Expert Consensus Documents covers not only the
integration of the most recent research, but also the creation of educational tools and …
integration of the most recent research, but also the creation of educational tools and …
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk …
D Poldermans, JJ Bax, E Boersma… - European Journal of …, 2010 - journals.lww.com
Guidelines for pre-operative cardiac risk assessment and per... : European Journal of
Anaesthesiology | EJA Guidelines for pre-operative cardiac risk assessment and perioperative …
Anaesthesiology | EJA Guidelines for pre-operative cardiac risk assessment and perioperative …
Coagulation cascade and therapeutics update: relevance to nephrology. Part 1: overview of coagulation, thrombophilias and history of anticoagulants
RLC Adams, RJ Bird - Nephrology, 2009 - Wiley Online Library
Coagulation involves the regulated sequence of proteolytic activation of a series of
zymogens to achieve appropriate and timely haemostasis in an injured vessel, in an …
zymogens to achieve appropriate and timely haemostasis in an injured vessel, in an …
General mechanisms of coagulation and targets of anticoagulants (Section I)
R De Caterina, S Husted, L Wallentin… - Thrombosis and …, 2013 - thieme-connect.com
Contrary to previous models based on plasma, coagulation processes are currently believed
to be mostly cell surface-based, including three overlapping phases: initiation, when tissue …
to be mostly cell surface-based, including three overlapping phases: initiation, when tissue …
Thrombin: a pivotal player in hemostasis and beyond
JB Larsen, AM Hvas - Seminars in Thrombosis and Hemostasis, 2021 - thieme-connect.com
The serine protease thrombin, a naturally derived enzyme, plays a key role in hemostasis by
converting fibrinogen to fibrin and activating coagulation factor XIII whereby the fibrin clot is …
converting fibrinogen to fibrin and activating coagulation factor XIII whereby the fibrin clot is …
Prediction of warfarin dose: why, when and how?
N Eriksson, M Wadelius - Pharmacogenomics, 2012 - Taylor & Francis
Prediction models are the key to individualized drug therapy. Warfarin is a typical example of
where pharmacogenetics could help the individual patient by modeling the dose, based on …
where pharmacogenetics could help the individual patient by modeling the dose, based on …
A tetracationic aggregation induced emission-based probe for efficient and improved detection of Heparin
Designing efficient fluorescent probes with Aggregation Induced Emission (AIE) feature,
especially for sensing biologically important analytes, is an intensive area of investigation …
especially for sensing biologically important analytes, is an intensive area of investigation …